Education

Education is an important part of the MSG mission statement: Education - Championing excellence and innovation in the development and delivery of evidence-based medical knowledge in invasive fungal disease management for patients globally.  The MSGERC sets an annual educational agenda based on current evidence in mycology and collaborates with the Education Committee and educational consultants to organize a variety of shared learning activities that meet the learning needs of infectious disease specialists, adult and pediatric internists, pharmacists, health care practitioners, and researchers. MSGERC educational offerings may range from high-level international forums, “air lifted” educational conferences and symposia and enduring activities providing web-accessible continuing medical education. These programs are generally for practitioners aiming to provide the best prevention, diagnosis and treatment of invasive fungal infections in normal and immunocompromised patient populations.

2019 Antifungal Drug Discovery Symposium

© Copyright Approved     

Join mycoses physicians and scientists for the 2019 Antifungal Drug Discovery Symposium taking place May 9-10 at Duke University!  The hefty agenda includes presentations by top fungal experts from around the globe, including members of the MSGERC.  Learn the latest discoveries, queries, and advancements in mycoses such as drug discovery hurdles, detailed antifungal targets and discovery methods, exploitations of fungal pathways for drug development, importance of PK/PD biofilms and clinical trials, and efforts of academia/industry to develop a new antifungal drug. The antifungal Drug Pipeline – a reality check!  Symposium registration is free; visit the Symposium webpage or email Christy Dixon for more information:

Thank you to the following dedicated physicians and scientists from around the world who will share their expertise and research in the field of invasive fungal infections at the Symposium:

* David Andes, MD: Chief, Division of Infectious Diseases, University of Wisconsin, Madison, WI USA
Yong-Sun Bahn, PhD: Professor, Dept. of Biotechnology, Yonsei University, Seoul, South Korea
Gerald Bills, PhD: Professor, University of Texas Health Science Center, Houston, TX USA
Axel Brakhage, PhD: Director, Leibniz Institute for Natural Product Research, Jena, Germany
Marty Burke, MD, PhD: Professor of Chemistry, University of Illinois, Urbana, IL USA
* Oliver Cornely, MD FACP, FIDSA: Scientific Director, Center of Clinical Trials, Cologne, Germany
Leah Cowen, PhD: Chair, Department of Molecular Genetics, University of Toronto, Toronto, ON Canada
Robert Cramer, PhD: Associate Professor, Geisel School of Medicine at Dartmouth, Hanover, NH USA
Maurizio Del Poeta, MD: Professor, Department of Molecular Genetics & Microbiology; Stony Brook University, Stony Brook, NY USA
David Fox III, PhD: Head of US Crystallography, UCB Biosciences, Raleigh, NC USA
John Galgiani, MD: Director, Valley Fever Center for Excellence; University of Arizona, Tucson, AZ USA
Neil A.R Gow, FRS, FRSE, FMedSci, FRSB; Professor and Deputy Vice Chancellor, University of Exeter, Devon, United Kingdom
William Hope, BMBS, FRACP, FRCPA, PhD: Professor, University of Liverpool, Liverpool, United Kingdom
Damian Krysan, MD, PhD: Director, Pediatric Infectious Disease, University of Iowa Health Care, Iowa City, IA USA
Han Lim, MD, PhD: Vice President, Global Head of Partnering, Atomwise, San Francisco, CA USA
John Rex, MD, FACP: Chief Medical Officer, F2G Ltd., Manchester, United Kingdom
Karen Joy Shaw, PhD: Chief Scientific Officer, Amplyx, San Diego, CA USA
Yeo-Joon Yoon, PhD: Professor of Chemistry and Nanoscience, Ewha Women’s University, Seoul, South Korea

* Member of The Mycoses Study Group Education & Research Consortium

The New Antifungal Toolkit 2019


We invite you to participate in the latest toolkit update: The New Antifungal Toolkit 2019: Review of Itraconazole Formulations and Application in Endemic Mycoses. In the first section, Dr Russell Lewis and Dr. Dimitrios P. Kontoyiannia provide an overview of conventional itraconazole capsules as well as the IV formulation. They then review the profile of SUBA-itraconazole, an itraconazole formulation with enhanced bioavailability that recently became commercially available in the United States. In the second section, Dr George Thompson provides an update on endemic mycoses, including a discussion of the place for SUBA-itraconazole in therapy. We hope you find this toolkit helpful in your care of patients with invasive fungal infections who are candidates for itraconazole therapy.

Registration and Information

Learning Objectives
At the conclusion of this activity, the participants will be better able to:

  • Compare and contrast newly FDA-approved and emerging antifungal agents/formulations with established antifungal therapeutics
  • Evaluate factors affecting the bioavailability of antifungal agents and their impact on efficacy/safety
  • Provide appropriate treatment for endemic fungi

Faculty
Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA, PhD Hon, FECMM, FAAM
Russell E. Lewis, PharmD, FCCP, BCPS
George R. Thompson III, MD, FACP

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Doctor Fungus Website


The DoctorFungus website was launched in the early 2000s and featured at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), December 2001.  The original website was spearheaded by Dr. John Rex and a team of collaborators from 3 continents and a dedicated web designer.  Over the last decade, the site became dormant.  In 2016 MSGERC relaunched the website under a new design and branding.  With the initial sponsorship by Astellas, the site is publicly available at www.drfungus.org.  This website features key updated encyclopedic features of the original site and includes Case of the Month.   To submit a case of the month, contact Peter G. Pappas, MD 


MSGERC Biennial Meeting

The MSGERC hosts a conference every two years whereby the fungal "state of the science" is presented by key opinion leaders in pre-clinical, veterinary, clinical areas.  The MSGERC Biennial Meeting provides an opportunity to generate new research concepts to address current and emerging unmet needs.  During this meeting academic investigators, junior investigators/fellows, private infectious disease practitioners, industry and government members join together for these common aims.  


MSGERC Education Initiatives

The Mycoses Study Group Education and Research Consortium (MSGERC) builds on its thirty-eight year legacy of scientific and academic expertise in mycology to collectively understand the needs of healthcare professionals in the field of mycology, institutions and companies worldwide. These include, but are not limited to the following:

  • Maintaining the desired level of expertise in a wide range of topics related to pre-clinical and clinical applications in mycology
  • Staying abreast of all cutting edge trends in mycology research for the prevention, diagnosis and disease management globally
  • Working endlessly to diagnose, treat and alleviate invasive fungal infections
  • Working to educate providers with state-of-the-art methods for treating invasive fungal infections

The MSGERC works with infectious disease key opinion leaders who have a broad range of expertise in a wide variety of patient populations, including oncology, rheumatology, pediatrics, HIV, and tropical medicine.  During its Biennial Meeting, the MSGERC invites key opinion leaders to present current pre-clinical, genomic, epidemiologic and clinical lectures addressing Endemic Mycoses, Cryptococcosis, Candidiasis, and Aspergillosis.  Each set of lectures is followed by facilitated discussions.  Video-taped lectures are featured on the MSGERC Youtube channel, Doctor Fungus website, and CDC Websites to disseminate information and learning opportunities.


CMEs

The MSGERC works in tandem with key CME providers Terranova Medica, LLC  and University of Nebraska Center of Continuing Education, School of Medicine.

Many CMEs are currently available at the MSGERC Continuing Education Portal www.FungusCME.org.


Publications

The MSGERC has disseminated findings from its multiple studies and activities through presentations at meetings and publications in peer-reviewed journals and book chapters.  A list of MSG Publications can be accessed on the Scholarship page.


Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines 


Upcoming Meetings of Interest

For your convenience, we have listed upcoming meetings for 2018.  You may see some of our members on the agenda.T

Meeting Dates URL Location
AAA - Advances against Aspergillosis Feb 1-3, 2018 http://aaa2018.org Lisbon, Portugal
ASM Conference on Candida Apr 15-10, 2018 http://www.asm.org Providence, RI
ASM Microbe Jun 7-11, 2018 http://www.asm.org  Atlanta, GA
ICHS- International Immunocompromised Host Sociaty Jun 17-19 , 2018 https://ichs2018.com Athens, Greece
ISHAM Jun 20-July4, 2018 http://isham2018.org  Amsterdam, The Netherlands
Molecular Mycology  Jul 30-Aug 15 http://www.mbl.edu/education/courses/molecular-mycology/ Woods Hole, MA
MSGERC BIENNIAL MEETING Sept 25-28, 2018 http://msgerc.org Big Sky, MT
ID Week Oct 3-7, 2018 http://idweek.org San Francisco, CA USA
CHEST Oct 6-10, 2018 http://chestmeeting.chestnet.org  San Antonio, TX
ASH Nov 28-Dec 4, 2018 http://hematology.org/meetings San Diego, CA


Important Links

In addition to our long-standing commitment to generating educational outreach, MSG-member scholarly activities continue to contribute to awareness and education of mycology topics and treatment guidelines globally, including:

 

MSGERC Education Committee Members

George Thompson, MD, Chair (US)

John Baddley, MD, Co-Chair (US)

Barbara Alexander, MD (US)

David Andes, MD (US)

John Bennett, MD (US)

Helen Boucher, MD (US)

Oliver Cornely, MD (DRG)

Graeme Forrest, MD (US)

Alison Freifeld, MD (US)

Susan Hadley, MD (US)

Dimitrios Kontoyiannis, MD (US)

Bart-Jan Kullberg, MD (NL)

Olivier Lortholary, MD (FR)

Marcio Nucci, MD (BR)

Luis Ostrosky-Zeichner, MD (US)

Peter Pappas, MD (US)

Tom Patterson, MD (US)

Monica Slavin, MD (AU)

Luis Thompson, MD (CH)


Consultants

Carolynn Thomas Jones, DNP, MSPH, RN, (MSGERC Executive Director) (US)

Lisa Tushla, PhD (Educational Consultant)

Tom Davis (Educational Consultant)

Lois Colburn (Educational Consultant)


        
 
(412) 344-2437
headquarters@msgerc.org

MSGERC Privacy Policy   

Powered by Wild Apricot Membership Software